Skip to main content

Advertisement

SpringerLink
Log in

A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Aim

Given the importance of epidemiological studies on the prevalence of human papilloma virus (HPV) and its subtypes to plan more effective strategies for cervical cancer prevention, the aim of this study was to determine the prevalence of HPV in women with cervical intraepithelial neoplasia and cancer in Isfahan.

Methods

In this descriptive cross-sectional study, women referred to oncology clinic of Shahid Beheshti Hospital because of abnormal cytology of their cervices within the last year were studied. The 2001 Bethesda system was used for histologic classification. The distribution of different pathologies was as follows: squamous cell carcinoma (SCC) 34.7%, low-grade squamous intraepithelial lesions (LSIL) 30.5%, high-grade squamous intraepithelial lesions (HSIL) 22.8%, atypical squamous cell of undetermined significance (ASCUS) 8.4%, and adenocarcinoma (AC) 3.3%. There was no case of atypical glandular of undetermined significance or cases of adenocarcinoma associated with an early lesion. The presence of HPV infection and its subtypes including HPV 16, 18, 6 and 11 was assessed in different cytological categories of cervical neoplasia, by using polymerase chain reaction method.

Results

During this study, 130 patients were studied. Their median age was 52 years (range 29–73 years). HPV was detected in 118/130 patients (90.8%) with abnormal cervical cytology. The prevalence of positive HPV samples was 97.6, 80, 93.1, 92.3, and 66.6% in cases with SCC, AC, HSIL, LSIL, and ASCUS, respectively (P < 0.05 between SCC and ASCUS, HSIL and ASCUS, and LSIL and ASCUS). Out of 118 cases with positive HPV, 98 (83.1%) were positive for multiple HPV types 16, 18, and 11 or 6. The distribution of studied HPV subtypes among women with positive HPV was as follows: 49.1% for both types 16 and 18, 10.1% for type 16, 1.69% for type 18 and 22% for type 11 or 6. The prevalence of HPV type 16 was not significantly different in various cytological categories of cervical neoplasia (P > 0.05). The prevalence of HPV type 16 and 18 was significantly higher than the HPV type 11 or 6 in cervical neoplastic lesions (P < 0.05).

Conclusion

The results of this research indicated the high prevalence of HPV infection in all categories of cervical neoplasia. This emphasizes the importance of HPV screening and vaccination programs. In order to assess more effective screening programs in Isfahan and evaluate the cost-effectiveness of vaccination programs, further population-based prospective studies are required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Qiao YL (2010) Perspective of cervical cancer prevention and control in developing countries and areas. Ai Zheng 29(1):1–3

    Google Scholar 

  2. Bulletin of the World Health Organization (BLT) (2010) World Health Organization available from: URL:http://www.who.int

  3. Ferlay J, Bray F, Pisani P, Parkin DM (2004) Cancer incidence, mortality and prevalence worldwide. In: Swanson D, Siegel JS, Henry S (eds) The methods and materials of demography. Emerald Group Publishing, Bingley

    Google Scholar 

  4. Parkin DM, Bray F, Ferlay J, Pisani P (2006) The burden of HPV-related cancers. In: Barrett ADT, Stanberry LR (eds) Vaccines for biodefense and emerging and neglected diseases. Academic Press, London, pp S11–S25

    Google Scholar 

  5. Nour NM (2009) Cervical cancer: a preventable death. Rev Obstet Gynecol 2(4):240–244

    PubMed  Google Scholar 

  6. Castellsague X, Diaz M, de Sanjose S, Muñoz N, Herrero R, Franceschi S et al (2006) International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Worldwide human papilloma virus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. JNCL 98(5):303–315

    Google Scholar 

  7. de Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur HH (2004) Classification of papilloma viruses. Virology 324(1):17–27

    Article  PubMed  Google Scholar 

  8. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al (1999) Human papilloma virus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19

    Article  PubMed  CAS  Google Scholar 

  9. Seoud MA, Seoud KM, Lindely S, Anis S (2010) Human papilloma virus (HPV): burden of the disease in cervical cancer in the Extended Middle East and North Africa (EMENA). A comprehensive review. J Clin Oncol 27(15S):e16577

    Google Scholar 

  10. Hamkar R, Mokhtari-Azad T, Mahmoodi M, Seyedirashti S, Severini A, Nategh R (2002) Prevalence of human papilloma virus in Mazandaran province, Islamic Republic of Iran. East Mediterranean Health J 8(6):805–811

    CAS  Google Scholar 

  11. Farjadian S, Asadi E, Doroudchi M, Dehaghani AS, Tabei SZ, Kumar VP et al (2003) High risk HPV types in southern Iranian patients with cervical cancer. Pathol Oncol Res 9(2):121–125

    Article  PubMed  CAS  Google Scholar 

  12. Mortazavi S, Zali M, Raoufi M, Nadji M, Kowsarian P, Nowroozi A (2002) The prevalence of human papilloma virus in cervical cancer in Iran. Asian Pac J Cancer Prev 3(1):69–72

    PubMed  Google Scholar 

  13. Sadeghi A, Sobhani A, Etaati Z, Jahanlu A, Shiroodi M (2008) Prevalence of human papilloma virus among women with cervical intraepithelial neoplasia III and invasive cervical cancer from 2001 to 2006 in Bandarabas. Iranian J Pathol 3:183–185

    Google Scholar 

  14. Jamali Zavarei M, Hamkar R, Ghobadi Dana V, Delforoosh M, Shojamoradi MH, Modarresi Gilani M (2008) Prevalence of HPV infection and its association with cytological abnormalities of pap smears in Tehran. Iranian J Publ Health 37:101–106

    Google Scholar 

  15. Hamkar R, Mokhtari-Azad T, Mahmoodi M, Seyedirashti S, Severini A, Nategh R (2003) Prevalence of various types of HPV among cervical cancer and normal biopsy in north of Iran. Iranian J Infect Dis Trop Med 8:9–15

    Google Scholar 

  16. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J et al (1995) Prevalence of human papilloma virus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87(11):796–802

    Article  PubMed  CAS  Google Scholar 

  17. Bao YP, Li N, Smith JS, Qiao YL (2008) Human papilloma virus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 18(1):71–79

    Article  PubMed  Google Scholar 

  18. Ghaffari SR, Sabokbar T, Mollahajian H, Dastan J, Ramezanzadeh F, Ensani F et al (2006) Prevalence of human papilloma virus genotypes in women with normal and abnormal cervical cytology in Iran. Asian Pac J Cancer Prev 7:529–532

    PubMed  Google Scholar 

  19. Niakan M, Yarandi F, Entezar M (2009) Human papilloma virus (HPV) detection in biopsies from cervical cancer patients; A population-based study from Iran. Iranian J Clin Infect Dis 4:35–37

    Google Scholar 

  20. Sun ZR, Ji YH, Zhou WQ, Zhang SL, Jiang WG, Ruan Q (2010) Characteristics of HPV prevalence among women in Liaoning province, China. Int J Gynaecol Obstet 109(2):105–109

    Google Scholar 

  21. Murillo R, Molano M, Martinez G, Mejia JC, Gamboa O (2009) HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country. Infect Dis Obstet Gynecol 2009:653598

    PubMed  Google Scholar 

  22. Bardin A, Vaccarella S, Clifford GM, Lissowska J, Rekosz M, Bobkiewicz P et al (2008) Human papilloma virus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer 44(4):557–564

    Article  PubMed  CAS  Google Scholar 

  23. Capra G, Giovannelli L, Bellavia C, Migliore MC, Caleca MP, Perino A et al (2008) HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy. Virus Res 133(2):195–200

    Article  PubMed  CAS  Google Scholar 

  24. Dursun P, Senger SS, Arslan H, Kuscu E, Ayhan A (2009) Human papilloma virus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis 9:191

    Article  PubMed  Google Scholar 

  25. Beskow AH, Gyllensten UB (2002) Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int J Cancer 101(6):526–531

    Article  PubMed  CAS  Google Scholar 

  26. Schwartz SM, Daling JR, Shera KA, Madeleine MM, McKnight B, Galloway DA et al (2001) Human papilloma virus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol 19(7):1906–1915

    PubMed  CAS  Google Scholar 

  27. Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA et al (2007) Efficacy of a quadrivalent prophylactic human papilloma virus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 369(9574):1693–1702

    Article  PubMed  CAS  Google Scholar 

  28. Chen CA, Liu CY, Chou HH, Chou CY, Ho CM, Twu NF et al (2006) The distribution and differential risks of human papilloma virus genotypes in cervical preinvasive lesions: a Taiwan Cooperative Oncologic Group Study. Int J Gynecol Cancer 16(5):1801–1808

    Article  PubMed  Google Scholar 

  29. Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL (2006) Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24 Suppl 3:S3/26–34

    Google Scholar 

  30. Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C (2009) Prevaccination distribution of human papilloma virus types in women attending at cervical cancer screening in Belgium. Cancer Epidemiol Biomarkers Prev 18(1):321–330

    Article  PubMed  CAS  Google Scholar 

  31. Moscicki AB, Hills N, Shiboski S et al (2001) Risks for incident human papillomavirus infection, low-grade squamous intraepithelial lesion development in young females. JAMA 285:2995

    Article  PubMed  CAS  Google Scholar 

  32. Zielinski GD, Snijders PJ, Rozendaal L et al (2001) HPV presence precedes abnormal cytology in women developing cervical cancer, signals false negative smears. Br J Cancer 85:398

    Article  PubMed  CAS  Google Scholar 

  33. Pett M, Coleman N (2007) Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 212(4):356–367

    Article  PubMed  CAS  Google Scholar 

  34. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ (2006) HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 208(2):152–164

    Article  PubMed  CAS  Google Scholar 

  35. Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC et al (2003) Human papilloma virus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 95(17):1336–1343

    PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Shahid Beheshti Hospital, Isfahan University of Medical Science, Motahari Street, Isfahan, Iran

    Tajossadat Allameh, Sharareh Moghim & Maryam Asadi-Zeidabadi

Authors
  1. Tajossadat Allameh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharareh Moghim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maryam Asadi-Zeidabadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tajossadat Allameh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allameh, T., Moghim, S. & Asadi-Zeidabadi, M. A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science. Arch Gynecol Obstet 284, 1509–1513 (2011). https://doi.org/10.1007/s00404-011-1863-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-011-1863-4

Keywords

Search

Navigation